Physician profile
Benjamin Brannick
NPI 1932693140
$2,533.75
in general payments reported to CMS, 2019-2025
13 companies · $628 in 2025
The $628 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $469 · 2023: $459 · 2024: $978 · 2025: $628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,064.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $715.05 | 2024-2025 | Krystexxa |
| Stryker Corporation | $538.52 | 2022-2023 | Ortholoc 2 Lapifuse, Sonicanchor, Fuseforce |
| Paratek Pharmaceuticals, INC. | $315.70 | 2023-2025 | Nuzyra |
| Averitas Pharma INC. | $273.27 | 2023-2025 | Qutenza |
| Kerecis Limited | $246.12 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $220.81 | 2023-2025 | Puraply Wound Matrix, Affinity, Apligraf |
| Prime Surgical, LLC | $51.39 | 2025 | |
| Triad Life Sciences INC. | $38.24 | 2022 | |
| Boston Scientific Corporation | $35.40 | 2024-2025 | General - Pain Management |
| Horizon Therapeutics Plc | $32.77 | 2022-2023 | Krystexxa |
| Nevro Corp. | $30.94 | 2024 | Senza |
| Grt US Holding, INC. | $19.77 | 2022 | |
| Medtronic, INC. | $15.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Brannick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.